Obesity pharmacotherapy: incretin action in the central nervous system

Overview of attention for article published in Trends in Pharmacological Sciences, November 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

blogs: 1 blog

twitter: 8 X users

Readers on

mendeley: 65 Mendeley

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 6,015 followers.

https://t.co/1p5BvJBKqA

RT @psychopharmacol: Review: tirzepatide, a dual agonist of receptors for the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose…

Review: tirzepatide, a dual agonist of receptors for the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), yields more weight loss than selective GLP-1 receptor (GLP-1R) agonists https://t.co/gDwhD…

RT @debbie_hay: Obesity pharmacotherapy: incretin action in the central nervous system https://t.co/McvaVVlqUi

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.